Skip to main content
. 2022 Nov 22;12(12):1949. doi: 10.3390/life12121949

Table 1.

Synthesis of the molecular characteristics that give plazomicin resistance to AMEs.

Plazomicin Molecular
Characteristics
Protection against AMEs Conferred from the Molecular Characteristics Traditional Aminoglycosides
Inactivated by AMEs
Lacks hydroxyl groups in the 3′ and 4′ positions O-nucleotidyltransferase (ANT(4′)) Amikacin and tobramycin
O-phosphotransferase (APH(3′)) Amikacin
Presence of unsaturated
hydroxyethyl group at position 6′
N-acetyltransferase (AAC(6′)) Amikacin, gentamicin and tobramycin
N-1 substitution with 4-amino-2-hydroxybutanoic acid N-acetyltransferase (AAC(3′)) Gentamicin and tobramycin
O-nucleotidyltransferase (ANT(2′)) Gentamicin and tobramycin
O-phosphotransferase (APH(2′)) Amikacin, gentamicin, and tobramycin